# Verapamil-Risperidone-DDI
Modeling of published verapamil-risperidone-DDI studies for model evaluation

## Repository files
Within this repository, we distribute a PK-Sim snapshot containing simulations of all published clinical studies used to evaluate the predictive performance of the verapamil and risperidone models regarding verapamil-risperidone-DDIs, including the respective observed data digitized from literature reports. The applied models have been published previously [1,2,3]. 

For further details and documentation please refer to [4].


## Version information

OSP Version 11.0

## License 
The model is distributed under the [GPLv2 Lincense](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE).

## Reference
[[1] Hanke N, Türk D, Selzer D, Wiebe S, Fernandez É, Stopfer P, Nock V, Lehr T. A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug-Drug Interaction Studies. Pharmaceutics. 2020 Jun 16;12(6):556. doi: 10.3390/pharmaceutics12060556. PMID: 32560124; PMCID: PMC7355632.](https://pmc.ncbi.nlm.nih.gov/articles/PMC7355632/)

[[2] Kneller, L.A., Abad-Santos, F. & Hempel, G. Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes. Clin Pharmacokinet 59, 51–65 (2020).](https://link.springer.com/article/10.1007/s40262-019-00793-x)

[[3] Rüdesheim, S.; Selzer, D.; Mürdter, T.; Igel, S.; Kerb, R.; Schwab, M.; Lehr, T. Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. Pharmaceutics 2022, 14, 1734.](https://www.mdpi.com/1999-4923/14/8/1734)

[[4] Rüdesheim S, Loer HLH, Feick D, Marok FZ, Fuhr LM, Selzer D, Teutonico, D, Schneider ARP, Solodenko J, Frechen S, vdL Maaike, Moes DJAR, Swen JJ, Schwab M, Lehr T. A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug Development. Clin Pharmacol Ther. 2025, doi: 10.1002/cpt.3604.](https://pubmed.ncbi.nlm.nih.gov/39953671/)
